Literature DB >> 18942034

Affective significance enhances covert attention: roles of anxiety and word familiarity.

Manuel G Calvo1, Michael W Eysenck.   

Abstract

To investigate the processing of emotional words by covert attention, threat-related, positive, and neutral word primes were presented parafoveally (2.2 degrees away from fixation) for 150 ms, under gaze-contingent foveal masking, to prevent eye fixations. The primes were followed by a probe word in a lexical-decision task. In Experiment 1, results showed a parafoveal threat-anxiety superiority: Parafoveal prime threat words facilitated responses to probe threat words for high-anxiety individuals, in comparison with neutral and positive words, and relative to low-anxiety individuals. This reveals an advantage in threat processing by covert attention, without differences in overt attention. However, anxiety was also associated with greater familiarity with threat words, and the parafoveal priming effects were significantly reduced when familiarity was covaried out. To further examine the role of word knowledge, in Experiment 2, vocabulary and word familiarity were equated for low- and high-anxiety groups. In these conditions, the parafoveal threat-anxiety advantage disappeared. This suggests that the enhanced covert-attention effect depends on familiarity with words.

Entities:  

Mesh:

Year:  2008        PMID: 18942034     DOI: 10.1080/17470210701743700

Source DB:  PubMed          Journal:  Q J Exp Psychol (Hove)        ISSN: 1747-0218            Impact factor:   2.143


  2 in total

1.  Evaluation of a novel translational task for assessing emotional biases in different species.

Authors:  Michael H Anderson; Chloë Hardcastle; Marcus R Munafò; Emma S J Robinson
Journal:  Cogn Affect Behav Neurosci       Date:  2012-06       Impact factor: 3.282

Review 2.  Automaticity in anxiety disorders and major depressive disorder.

Authors:  Bethany A Teachman; Jutta Joormann; Shari A Steinman; Ian H Gotlib
Journal:  Clin Psychol Rev       Date:  2012-07-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.